These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36757045)

  • 1. Successful TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for a Patient With Artemis Deficiency.
    Tomomasa D; Isoda T; Mitsuiki N; Inoue K; Nishimura A; Uda K; Uchiyama T; Yamashita M; Kamiya T; Endo A; Takagi M; Imai K; Kajiwara M; Cowan MJ; Morio T; Kanegane H
    J Pediatr Hematol Oncol; 2023 Mar; 45(2):e285-e289. PubMed ID: 36757045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency.
    Tsilifis C; Lum SH; Nademi Z; Hambleton S; Flood TJ; Williams EJ; Owens S; Abinun M; Cant AJ; Slatter MA; Gennery AR
    J Clin Immunol; 2022 May; 42(4):851-858. PubMed ID: 35305204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3
    Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
    Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor αβ
    Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
    J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
    Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
    Front Immunol; 2020; 11():699. PubMed ID: 32477328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
    Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
    Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
    Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity.
    Lum SH; Greener S; Perez-Heras I; Drozdov D; Payne RP; Watson H; Carruthers K; January R; Nademi Z; Owens S; Williams E; Waugh S; Burton-Fanning S; Leahy TR; Cant A; Abinun M; Flood T; Hambleton S; Gennery AR; Slatter M
    Blood Adv; 2022 Feb; 6(4):1319-1328. PubMed ID: 34972212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of TCR α
    Brettig T; Smart J; Choo S; Mechinaud F; Mitchell R; Raj TS; Cole T
    J Clin Immunol; 2019 Jul; 39(5):505-511. PubMed ID: 31172381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Full Donor T-Cell Chimerism After Haploidentical TCRαβ/CD19 Depleted HSCT Maintains Remission of Familial HLH.
    Consonni F; Coniglio ML; ; Sieni E; Gambineri E
    J Clin Immunol; 2023 Dec; 44(1):22. PubMed ID: 38129595
    [No Abstract]   [Full Text] [Related]  

  • 13. Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.
    Laberko A; Sultanova E; Gutovskaya E; Radygina S; Deripapa E; Kantulaeva A; Trakhtman P; Brilliantova V; Starichkova J; Shcherbina A; Maschan M; Maschan A; Balashov D
    J Clin Immunol; 2020 Aug; 40(6):861-871. PubMed ID: 32602054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
    Bethge WA; Eyrich M; Mielke S; Meisel R; Niederwieser D; Schlegel PG; Schulz A; Greil J; Bunjes D; Brecht A; Kuball J; Schumm M; Vucinic V; Wiesneth M; Bonig H; Westinga K; Biedermann S; Holtkamp S; Karitzky S; Malchow M; Siewert C; Handgretinger R; Lang P
    Bone Marrow Transplant; 2022 Mar; 57(3):423-430. PubMed ID: 34952929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical CD3 TCRαβ and CD19-depleted second stem cell transplant for steroid-resistant acute skin graft versus host disease.
    Slatter M; Nademi Z; Leahy TR; Morillo-Gutierrez B; Dunn J; Barge D; Skinner R; Ryan C; Hambleton S; Abinun M; Flood T; Cant A; Gennery A
    J Allergy Clin Immunol; 2016 Aug; 138(2):603-605.e1. PubMed ID: 27016800
    [No Abstract]   [Full Text] [Related]  

  • 16. Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies.
    Laberko A; Sultanova E; Gutovskaya E; Shipitsina I; Shelikhova L; Kurnikova E; Muzalevskii Y; Kazachenok A; Pershin D; Voronin K; Shcherbina A; Maschan M; Maschan A; Balashov D
    Blood; 2019 Nov; 134(20):1755-1763. PubMed ID: 31558465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.
    Pulsipher MA; Ahn KW; Bunin NJ; Lalefar N; Anderson E; Flower A; Cairo MS; Talano JA; Chaudhury S; Kitko CL; Duke JL; Monos D; Leung W; Dvorak CC; Abdel-Azim H
    Blood; 2022 Dec; 140(24):2556-2572. PubMed ID: 35776909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.
    Leahy AB; Li Y; Talano JA; Elgarten CW; Seif AE; Wang Y; Johnson B; Monos DS; Kadauke S; Olson TS; Freedman J; Wray L; Grupp SA; Bunin N
    Blood Adv; 2022 Feb; 6(4):1175-1185. PubMed ID: 34872106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency.
    Laberko A; Idarmacheva A; Glushkova S; Pershin D; Shelikhova L; Maschan M; Maschan A; Balashov D
    Transplant Cell Ther; 2022 Mar; 28(3):172.e1-172.e4. PubMed ID: 34875404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.